मूलभूत आँकड़े
| LEI | 391200TTZP8EIPSJ5J20 |
| CIK | 1651595 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Basilea Pharmaceutica AG
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| December 9, 2015 |
Basilea Pharmaceutica REQUEST FOR WITHDRAWAL Request for Withdrawal Basilea Pharmaceutica Ltd. Grenzacherstrasse 487 4058 Basel, Switzerland December 9, 2015 VIA EDGAR AND FEDEX United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F. Street N.E. Washington, DC 20549 Attention: Suzanne Hayes Re: Basilea Pharmaceutica Ltd./Application for Withdrawal on Form RW for Registration Statement on Form F- |
|
| October 30, 2015 |
Basilea Pharmaceutica AMENDMENT NO.1 TO FORM F-1 Amendment No.1 to Form F-1 Table of Contents As filed with the United States Securities and Exchange Commission on October 30, 2015 Registration No. 333-207457 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Basilea Pharmaceutica Ltd. (Exact name of registrant as specified in its charter) Sw |
|
| October 16, 2015 |
Basilea Pharmaceutica FORM F-1 Form F-1 Table of Contents As filed with the United States Securities and Exchange Commission on October 16, 2015 Registration No. |
|
| October 9, 2015 |
DRS/A Amendment 1 Table of Contents As confidentially submitted with the United States Securities and Exchange Commission on October 9, 2015 as Amendment No. |
|
| September 4, 2015 |
DRS Table of Contents As confidentially submitted with the United States Securities and Exchange Commission on September 4, 2015. |
